cholesterol
| 3 min read
A gene therapy targeting ANTIGPTL3 reduced cholesterol and triglyceride levels simultaneously.
| 3 min read
Sagimet’s denifanstat delivered significant improvements in disease activity and fibrosis for patients with metabolic dysfunction-associated steatohepatitis.
Page 1 of 1 - 2 Total Items
